Latest Insider Transactions at Aptevo Therapeutics Inc. (APVO)
This section provides a real-time view of insider transactions for Aptevo Therapeutics Inc. (APVO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aptevo Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aptevo Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 01
2022
|
John Niederhuber |
BUY
Exercise of conversion of derivative security
|
Direct |
298
+14.11%
|
-
|
Jan 29
2022
|
Jeffrey G. Lamothe EVP, COO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,833
+20.31%
|
-
|
Jan 29
2022
|
Marvin L White President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,792
+15.68%
|
-
|
Dec 03
2021
|
Fuad El Hibri Director |
BUY
Other acquisition or disposition
|
Indirect |
124,999
+50.0%
|
-
|
Nov 23
2021
|
Tang Kevin C |
SELL
Open market or private sale
|
Indirect |
921,336
-34.33%
|
$10,134,696
$11.29 P/Share
|
Nov 22
2021
|
Tang Kevin C |
SELL
Open market or private sale
|
Indirect |
255,331
-5.69%
|
$1,531,986
$6.92 P/Share
|
Nov 19
2021
|
Tang Kevin C |
SELL
Open market or private sale
|
Indirect |
213,800
-7.84%
|
$1,496,600
$7.77 P/Share
|
Nov 18
2021
|
Tang Kevin C |
SELL
Open market or private sale
|
Indirect |
369,533
-5.62%
|
$2,956,264
$8.45 P/Share
|
Nov 06
2020
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
174,277
+2.44%
|
$3,834,094
$22.58 P/Share
|
Nov 05
2020
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
625,723
+7.18%
|
$11,263,014
$18.39 P/Share
|
Nov 04
2020
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
636,675
+13.93%
|
$8,913,450
$14.07 P/Share
|
Jun 14
2019
|
John Niederhuber |
BUY
Open market or private purchase
|
Direct |
714
+32.02%
|
$0
$0.91 P/Share
|